Dermata Therapeutics announces $3.4M at-the-market private placement
Dermata Therapeutics (DRMA) announces a $3.4 million private placement priced at-the-market under Nasdaq rules, with details not provided in the feed.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.